Single-fraction SBRT viable for localized prostate cancer, study suggests

A new study suggests single-fraction stereotactic body radiotherapy (SBRT) is a valid treatment option for localized prostate cancer.

• The news report highlights that single-fraction SBRT may be an effective alternative to multi-fraction regimens.
• See source for details.

RadPigeon summaries are original and for information only. They are not clinical advice.